{"nct_id":"NCT05412030","title":"A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-11","start_date":"2022-06-16","start_date_type":"ACTUAL","primary_completion_date":"2026-07-23","primary_completion_date_type":"ESTIMATED","completion_date":"2026-07-23","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["GSK"]}